Canada markets closed

Telescope Innovations Corp. (TELIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2575+0.0001 (+0.04%)
At close: 09:37AM EDT

Telescope Innovations Corp.

301 - 2386 East Mall
Vancouver, BC V6T 1Z3
Canada
778-262-1166
https://www.telescopeinnovations.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Henry DubinaCEO & Chairman of BoardN/AN/AN/A
Mr. John KirincicChief Financial OfficerN/AN/AN/A
Dr. Jeffrey W. Sherman Ph.D.Chief Operating OfficerN/AN/AN/A
Prof. Jason HeinCTO & Director146.45kN/AN/A
Ms. Deborah CotterCompany SecretaryN/AN/AN/A
Shad GrunertVice President of Innovation4.82kN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry. The company is based in Vancouver, Canada.

Corporate Governance

Telescope Innovations Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.